Epinogen

Epinogen

Advancing cancer care with Epinogen’s next-gen Cryo-EM based therapeutics—transforming treatment and enriching patient lives.

Epinogen is a trailblazing biotech company developing next-generation anticancer drugs using advanced Cryo-EM technology.

Vision and Mission: Epinogen’s vision is to lead the fight against cancer with cutting-edge research and innovative therapeutics. Their mission is to provide effective medication treatments that improve the lives of cancer patients worldwide.

Noteworthy Points:

  • Founded in 2019, Epinogen is pioneering in the field of drug discovery.
  • They have a robust pipeline with four leading and five follow-up projects aimed at continuous development and licensing.
  • The company’s expertise is recognized in ultra-low temperature electron microscope structure identification, new drug target giant protein production, and ultra-fast structure-based ligand optimization.

 

Picture Gallery

Comments are closed.